IRRAS Expands Intellectual Property Portfolio with Issuance of Additional Patent for IRRAflow System
· Third patent issued to expand protection of company’s IRRAflow® system, the world’s first irrigating intracranial drainage system. · The issued patent provides coverage of the IRRAflow system’s ability to administer therapeutic drugs using its catheter’s dual-lumen design and controlled irrigation capabilities.Stockholm, January 12, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced the issuance of United States (U.S.) Patent Number 11,123,483, “Fluid Exchange Catheter System.” This